Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 488

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 488
---
 1,882,656 
 874,238   
 2,756,894 
 —         
 —         | ) 
 ) |     | 2024 | (1,280,887 
     58,621 
          — 
          — 
 (1,222,266 
  2,005,351 
    783,085 
          — 
          — | ) 
 ) |
|:-------------------------------------------------------------------------|:----|:-------------------------|:----------|:--|:----|:-----|-----------:|:--|
| Settlement of deferred cash bonus by issuance of share options or shares |     | $                        | —         |   |     |      |    451,660 |   |

See accompanying notes to the unaudited condensed consolidated financial statements.

F-37 APTORUM GROUP LIMITED NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Stated in U.S. Dollars) 1. ORGANIZATION The unaudited condensed consolidated financial statements include the financial statements of Aptorum Group Limited (the “Company”) and its subsidiaries of which the Company is the primary beneficiary (collectively the “Group”). The Company, formerly known as APTUS Holdings Limited and STRIKER ASIA OPPORTUNITIES FUND CORPORATION, is a company incorporated on September 13, 2010 under the laws of the Cayman Islands with limited liability. The Company researches and develops life science and biopharmaceutical products within its wholly -ownedsubsidiary, Aptorum Therapeutics Limited, formerly known as APTUS Therapeutics Limited (“Aptorum Therapeutics”) and its indirect subsidiary companies (collectively, “Aptorum Therapeutics Group”). 2. GOING CONCERN The Group reported a net loss of $ 449,295, working capital of $ 1,998,298and net operating cash outflow of $ 816,544for the six months ended June 30, 2025. In addition, the Group had an accumulated deficit of $ 72,871,308as of June 30, 2025. The Group’s operating results for future periods are subject to numerous uncertainties and it is uncertain if the Group will be able to reduce or eliminate its net losses for the foreseeable future. If management is not able to generate significant revenues from its product candidates currently in development, the Group may not be able to achieve profitability. Successful transition to attaining profitable operations is dependent upon achieving a